Supernus Pharmaceuticals Inc (SUPN)

Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

GlobeNewswire Inc.

Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics

Zacks Investment Research

Supernus Announces First Quarter 2024 Financial Results

GlobeNewswire Inc.

Ahead of Supernus (SUPN) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks Investment Research

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

GlobeNewswire Inc.

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

GlobeNewswire Inc.

Supernus Provides Regulatory Update for SPN-830

GlobeNewswire Inc.

Supernus to Participate in Two Upcoming Investor Conferences

GlobeNewswire Inc.

Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference

GlobeNewswire Inc.

Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks Investment Research

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates

Zacks Investment Research

Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire Inc.

Ahead of Supernus (SUPN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks Investment Research

BridgeBio Pharma (BBIO) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research

Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

GlobeNewswire Inc.

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

GlobeNewswire Inc.